Cargando…
Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery
Schistosomiasis is a major endemic disease known for excessive mortality and morbidity in developing countries. Because praziquantel is the only drug available for its treatment, the risk of drug resistance emphasizes the need to discover new drugs for this disease. Cathepsin SmCL1 is the critical t...
Autores principales: | Zafar, Atif, Ahmad, Sabahuddin, Rizvi, Asim, Ahmad, Masood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416924/ https://www.ncbi.nlm.nih.gov/pubmed/25933436 http://dx.doi.org/10.1371/journal.pone.0123996 |
Ejemplares similares
-
SmCL3, a Gastrodermal Cysteine Protease of the Human Blood Fluke Schistosoma mansoni
por: Dvořák, Jan, et al.
Publicado: (2009) -
Reduction of liquid terminated-carboxyl fluoroelastomers using NaBH(4)/SmCl(3)
por: Chang, Yunfei, et al.
Publicado: (2020) -
Drug-Induced Exposure of Schistosoma mansoni Antigens SmCD59a and SmKK7
por: Reimers, Natalie, et al.
Publicado: (2015) -
In Silico Analysis of Common Long Noncoding RNAs in Schistosoma mansoni and Schistosoma haematobium
por: Sirekbasan, Serhat, et al.
Publicado: (2021) -
Histone deacetylase 8 interacts with the GTPase SmRho1 in Schistosoma mansoni
por: Pagliazzo, Lucile, et al.
Publicado: (2021)